Generic companies drooling over on Lyrica’s market

A series of generics are being developed to target the Lyrica’s(pregabalin)patent expiration date for its pain indication. The number of products that were newly approved this year reaches 30 products.

Since tens of products will be added in this speed, they are expected to compete over the annual KRW 40 billion market.

According to the estimation result of the Ministry of Food and Drug Saf...